Company Analysis

Biomerica, Inc. (BMRA)

Nasdaq: BMRA · In Vitro & In Vivo Diagnostic Substances · Irvine, CA · filing with the SEC since 1995
Grade3.7
◀ Past 3.2● Present 3.5▶ Future 4.2
1 est.

Who runs Biomerica, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Irani Zackary S.
Chief Executive Officer. First filing Jun 2006, latest Aug 27, 2026, 22 filings in all.
Officers reporting now
4
of 7 people with a filing in the last fifteen months
Directors reporting now
3
15 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Qu XiaoxuanPrincipal Financial Officer and Principal Accounting OfficerSep 2026Sep 8, 2026none
Irani Zackary S.Chief Executive OfficerJun 2006Aug 27, 2026none
Barbieri AllenExecutive Vice ChairmanJun 2006Aug 27, 2026none
Lu GaryChief Financial OfficerMar 2023Dec 31, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Chin EricdirectorJun 2025Aug 27, 2026none
Gary M. HuffdirectorDec 2025Aug 27, 2026none
Moatazedi DaviddirectorAug 2023Aug 27, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
B. Riley Principal Capital, LLC10% ownerSep 2026Sep 10, 2026none
Brc Group Holdings, Inc.10% ownerSep 2026Sep 10, 2026none
Riley Bryant R10% ownerSep 2026Sep 10, 2026none
Earlier names on the record9, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton BMRA · research, not advice